VIV:CC News and Press, Avivagen Inc. From 05/31/22

VIV:CC - Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares and Warrants for Proceeds of Up to $5.0 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products ...

VIV:CC - Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

VIV:CC - Avivagen Announces Approval in China, the World's Largest Commercial Feed Production Market

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

VIV:CC - Avivagen Provides Update on Non-Brokered Private Placement

Not for Distribution to United States News Wire Services or for Dissemination in the United States. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”) announces that the TSX Venture Exchange has granted an extension of up to 30 day...

VIV:CC - Avivagen Inc. Announces Closing of First Tranche of a Private Placement of Shares and Warrants for Proceeds of up to $5.0 Million

Not for Distribution to United States News Wire Services or for Dissemination in the United States. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products ...

VIV:CC - Avivagen Announces AGM Results and Update to Shareholders

Record Year of Progress for OxC-beta TM Adoption Worldwide Supply agreement with AB Vista in United States, Brazil and Thailand compliments existing partnerships in Asia and Mexico Continued positive animal trial results leading to orders, new customer wins...

VIV:CC - Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2022

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

VIV:CC - Avivagen Announces Closing of Private Placement of Debentures and Shares

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sci...

VIV:CC - Avivagen Inc. (VIVXF)(VIV:CA) - A Debt for a Debt

The New Offering. Avivagen's management announced yesterday the intention to complete a private placement financing of secured debentures. The gross proceeds of this financing will total up to CAD$6.5 million and will close on March 28, 2022. Bloom Burton Securities is acting as the agent in t...

VIV:CC - Avivagen Announces Proposed Private Placement of Debentures and Shares and Issuance of Shares in Lieu of Maintenance Fees

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sci...

Company Name:	Avivagen Inc.
Stock Symbol:	VIV:CC
Market:	TSXVC